Jamie Smith reports from San Francisco
After the Chinese government grants Pfizer the license to locally produce and supply Nematevir/Ritonavir tablets (trade name: Paxlovid), Pfizer can start production in China through a Chinese partner within three to four months. This new crown oral medicine is produced locally.
Pfizer Chief Executive Albert Bourla said on Monday that a Chinese drugmaker with an outsourcing contract was preparing to invest in the production of the oral antiviral drug as supplies in China are tight and demand is soaring. Last year, Pfizer and Zhejiang Huahai Pharmaceutical (Huah…
